Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
September 12, 2026
Seoul
ADT Intensification: The Evidence You Can’t Afford to Miss
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Molecular Profiling in mHSPC: Informing Treatment Selection
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
EHA 2026: Sonrotoclax Plus Zanubrutinib in Frontline CLL
Chan Y. Cheah, MBBS
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
Maria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
Case: Implementing ADT Intensification in mHSPC
Targeting PTEN: Why It Matters
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD
Michael Dolinger, MD, MBA
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
De Novo mHSPC: Recognizing the Patients Who Need More
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
Putting It All Together: Challenges Addressed
Beyond Biology: Environmental and Lifestyle Influences in IBD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.